Japan Clinical Cancer Research Organization   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Tokyo Japan (1990)

Organization Overview

First Clinical Trial
2006
NCT00287755
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now